FDA recall D-0860-2016

Lipo Escultura Corp. · Class I · drug

Product

LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp., BROOKLYN, NY 11238, www.lipoesculturatreatment.com

Reason for recall

Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.

Distribution

Nationwide via Internet sales

Key facts

Status
Terminated
Initiation date
2015-12-03
Report date
2016-06-01
Termination date
2017-04-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Brooklyn, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0860-2016